Individuals with behavioral health diagnoses smoke at 2 to 3 times the rate of the general U.S. population. This group is an important target for tobacco cessation. However, many providers are not comfortable with using pharmacotherapies for tobacco cessation in this population. This training is designed for physicians, physician assistants, nurse practitioners, pharmacists and tobacco treatment specialists who work in an inpatient psychiatric hospital setting and who would benefit from an understanding of the current research guiding smoking cessation pharmacotherapy. The course will provide an overview of the neurobiology that gives rise to nicotine dependence and how various medications impact that neurobiology. We will provide guidance on treatment that is relevant to most clinicians. We will explore specific cases, such as use of tobacco treatment medications in hospitalized patients, patients with mental illness or co-occurring disorders, and adolescent treatment. The course is designed to provide practical guidance for clinicians and lead to real change in clinical practice.​